According to Carisma Therapeutics's latest financial reports the company's current EPS (TTM) is -2,91ย โฌ. In 2021 the company made an earnings per share (EPS) of -0,96ย โฌ a decrease over its 2020 EPS that were of -0,67ย โฌ.